- Home
- SIEB vs ARCT Comparison
SIEB vs ARCT Comparison
Compare SIEB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | ARCT |
|---|---|---|
| Founded | 1886 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SIEB | ARCT |
|---|---|---|
| Price | $3.58 | $6.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.67 |
| AVG Volume (30 Days) | 26.9K | ★ 700.6K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $90,289,000.00 | ★ $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | ★ 8.32 | N/A |
| 52 Week Low | $2.08 | $5.85 |
| 52 Week High | $5.77 | $24.17 |
Technical Indicators
Market Signals| Indicator | SIEB | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 50.56 | 33.50 |
| Support Level | $3.45 | $6.02 |
| Resistance Level | $3.93 | $6.75 |
| Average True Range (ATR) | 0.28 | 0.30 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 21.12 | 8.44 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.